Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial
Authors:
Top Cited Papers
Open Access
- 24 April 2024
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 71, 102610
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (2009326)
- National Health and Medical Research Council (1104231)
- National Health and Medical Research Council (OLL-942177)
- National Health and Medical Research Council (OLL-970566)
This publication has 30 references indexed in Scilit:
- Association between number of abnormal glucose values and severity of fasting plasma glucose in IADPSG criteria and maternal outcomes in women with gestational diabetes mellitusActa Diabetologica, 2021
- Screening for Gestational DiabetesJAMA, 2021
- Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: A systematic review and meta-analysisDiabetes Research and Clinical Practice, 2021
- Early gestational diabetes screening in obese women: a randomized controlled trialAmerican Journal of Obstetrics and Gynecology, 2020
- Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: a Systematic Review and Meta-analysisCurrent Diabetes Reports, 2017
- Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in EuropeDiabetologia, 2017
- A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled TrialsPharmacoEconomics, 2014
- COST‐MINIMISATION ANALYSIS VERSUS COST‐EFFECTIVENESS ANALYSIS, REVISITEDHealth Economics, 2011
- Treating mild gestational diabetes mellitus: a cost-effectiveness analysisAmerican Journal of Obstetrics and Gynecology, 2011
- The death of cost‐minimization analysis?Health Economics, 2001